Antonio Petracca

Safety and efficacy of propranolol for treatment of familial cerebral cavernous malformations (Treat_CCM): a randomised, open-label, blinded-endpoint, phase 2 pilot trial

Silvia Lanfranconi, Elisa Scola, Jennifer Meessen et al. · The Lancet Neurology · 2022 · 62 citations · Full text

Medicine, Neurology, Neuro-oncology +4

Propranolol for familial cerebral cavernous malformation (Treat_CCM): study protocol for a randomized controlled pilot trial

Silvia Lanfranconi, Elisa Scola, Giulio Bertani et al. · Trials · 2020 · 50 citations · Full text

Medicine, Neurology, Neurosurgery +13

A novel dominant-negative FGFR1 variant causes Hartsfield syndrome by deregulating RAS/ERK1/2 pathway

Pietro Palumbo, Antonio Petracca, Roberto Maggi et al. · European Journal of Human Genetics · 2019 · 20 citations · Full text

Life Sciences, Genetics, Molecular Genetics +13

Customised next-generation sequencing multigene panel to screen a large cohort of individuals with chromatin-related disorder

Gabriella Maria Squeo, Bartolomeo Augello, Valentina Massa et al. · Journal of Medical Genetics · 2020 · 20 citations

Life Sciences, Genetics, Molecular Genetics +17

Mutational spectrum and clinical signatures in 114 families with hereditary multiple osteochondromas: insights into molecular properties of selected exostosin variants

Carmela Fusco, Grazia Nardella, Rita Fischetto et al. · Human Molecular Genetics · 2019 · 19 citations

Life Sciences, Genetics, Molecular Genetics +17